What is Theravance Biopharma's net debt / EBITDA?

Theravance Biopharma (TBPH) reported net debt / EBITDA of -84.1× in Q1 2026.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Theravance Biopharma (TBPH) Net debt / EBITDA

Screener

Net debt / EBITDA at other companies

Gyre Therapeutics, Inc.GYRE

-5×-5.8×

Rigel PharmaceuticalsRIGL

0.3×+0.2×

Royalty PharmaRPRX

5.2×+1.4×

Zevra Therapeutics, Inc.ZVRA

-1.6×—

Aurinia PharmaceuticalsAUPH

-0.6×-1.2×

Mirum Pharmaceuticals, Inc.MIRM

-116.1×—

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$876.93M+53.9%

Enterprise value$629.34M+88.3%

P/E7.7×-36.1×

P/S8×+0.6×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Calculated from Theravance Biopharma’s reported figures.

net debt/ebitda=-84.1×

Based on the most recent quarter.

The source filing: Theravance Biopharma’s 10-Q, filed May 7, 2026. Open the filing →

Filed: May 7, 2026, 9:00 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001104659-26-056760

FAQ

What is Theravance Biopharma's net debt / EBITDA?: Theravance Biopharma (TBPH) reported net debt / EBITDA of -84.1× in Q1 2026.
What does net debt / EBITDA mean?: Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Ask your AI about Theravance Biopharma's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Theravance Biopharma TBPH Net debt / EBITDA

Net debt / EBITDA at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Theravance Biopharma's net debt / ebitda.